Review for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

Mapping Intimacies ◽

10.1002/eji.201948375/v1/review1 ◽

2019 ◽

Author(s):

Nicolas Dulphy

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo

European Journal of Immunology ◽

10.1002/eji.201948375 ◽

2020 ◽

Vol 50 (9) ◽

pp. 1374-1385 ◽

Author(s):

Xiang‐Yu Zhao ◽

Qian Jiang ◽

Hao Jiang ◽

Li‐Juan Hu ◽

Ting Zhao ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Review for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v2/review2 ◽

2020 ◽

Author(s):

Nicolas Dulphy

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Decision letter for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v2/decision1 ◽

2020 ◽

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Review for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v3/review1 ◽

2020 ◽

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Author response for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v2/response1 ◽

2019 ◽

Author(s):

Xiang‐Yu Zhao ◽

Qian Jiang ◽

Hao Jiang ◽

Li‐Juan Hu ◽

Ting Zhao ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Author Response ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Decision letter for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v1/decision1 ◽

2019 ◽

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Author response for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v3/response1 ◽

2020 ◽

Author(s):

Xiang‐Yu Zhao ◽

Qian Jiang ◽

Hao Jiang ◽

Li‐Juan Hu ◽

Ting Zhao ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Author Response ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Review for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v2/review1 ◽

2020 ◽

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Review for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v1/review2 ◽

2019 ◽

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text

Decision letter for "Expanded clinical‐grade membrane‐bound IL‐21/4‐1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo"

10.1002/eji.201948375/v3/decision1 ◽

2020 ◽

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Nk Cell ◽

Clinical Grade ◽

Membrane Bound ◽

Download Full-text